Renescience A/S: Financial statements 2012
CVR: 31846803
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Renescience A/S (CVR 31846803) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -20,994,000 and a net result of DKK -16,641,000. Equity in the 2012 report amounted to DKK 17,605,000. The solvency ratio was 74%.
- Gross Profit
- DKK -20,994,000
- Profit/Loss
- DKK -16,641,000
- Equity
- DKK 17,605,000
- Total Assets
- DKK 23,778,000
Keep an eye on Renescience A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of August 27, 2012, Henrik Maimann is registered as director of Renescience A/S.
As of August 27, 2012, Nanna Dreyer Nørholm has stepped down as director of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RENESCIENCE A/S and DE S&D NR. 1 2008 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. According to the 2025 annual report, the company had an average of 1,000 employees. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity in the 2025 report amounted to DKK 73,470,000.